Researchers Feel Impact of Shutdown As Grant Review Stops, Funding Runs Dry
In Brief: Gift To St. Jude: $1 Million McDonald’s Ticket; Leitch Elected President, ACS Texas Division
FDA carries Action On Two Cancer Drugs Over To 1996
NRC Reports Says NIH Security Of nuclear Materials a Problem
Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial?
AACR, Kellogg’s Co. Sponsor Award
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - Alec Kimmelman announced as next CEO and Dean of NYU Langone Health
